-
Founded in:
1993-07-03 -
Country:
China -
Address:
No. 2428, Anji Road, Sanzao Town, Jinwan District, Zhuhai City -
Tax NO.:
91440400618249510X -
Registered Funds:
1.7623158 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefetamet pivoxil hydrochloride |
Unspecified
More
Unspecified |
111696-23-2 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 3，5-dimethyl-Tricyclo[3.3.1.13,7]decan-1-amine |
Extract from the above information
More
Extract from the above information |
51052-62-1 | 56 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefaclor |
The antibacterial properties are similar to those of cefazolin, and it has good antibacterial effects on Staphylococci (including enzyme-producing strains), Streptococcus pyogenes, Pneumococcus, Escherichia coli, Proteus mirabilis, Haemophilus influenzae, etc. Cefaclor is a second-generation oral cephalosporin, and its antibacterial effect is stronger than that of cefadroxil. Its activity against group A hemolytic streptococci, viridans streptococci, and Staphylococcus epidermidis is the same as that of cefadroxil; its antibacterial activity against pneumococci and non-enzyme-producing Staphylococcus aureus is 2 to 4 times stronger than that of cefadroxil, and its activity against enzyme-producing Staphylococcus aureus is the same. The MIC for Salmonella and Shigella is 0.25 to 1 mg/L, which is 8 times stronger than cefadroxil, and the MIC for gonococci is 0.016 to 1 mg/L. Many beta-lactamase-producing influenza bacilli are sensitive to this product; most common Proteus, Serratia, Acinetobacter, and Pseudomonas aeruginosa are resistant to this product.
More
The antibacterial properties are similar to those of cefazolin, and it has good antibacterial effects on Staphylococci (including enzyme-producing strains), Streptococcus pyogenes, Pneumococcus, Escherichia coli, Proteus mirabilis, Haemophilus influenzae, etc. Cefaclor is a second-generation oral cephalosporin, and its antibacterial effect is stronger than that of cefadroxil. Its activity against group A hemolytic streptococci, viridans streptococci, and Staphylococcus epidermidis is the same as that of cefadroxil; its antibacterial activity against pneumococci and non-enzyme-producing Staphylococcus aureus is 2 to 4 times stronger than that of cefadroxil, and its activity against enzyme-producing Staphylococcus aureus is the same. The MIC for Salmonella and Shigella is 0.25 to 1 mg/L, which is 8 times stronger than cefadroxil, and the MIC for gonococci is 0.016 to 1 mg/L. Many beta-lactamase-producing influenza bacilli are sensitive to this product; most common Proteus, Serratia, Acinetobacter, and Pseudomonas aeruginosa are resistant to this product. |
53994-73-3 | 29 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefuroxime 1-acetoxyethyl ester |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
64544-07-6 | 17 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Imiquimod |
Unspecified
More
Unspecified |
99011-02-6 | 16 |